Nodal metastasis mapping in seminoma (RT fields)
ForCS IIA/B or recurrent CS I seminoma post-orchiectomy, nodes ≤5cm
TL;DRAcross 145 imaging-positive nodes in 90 pts, 99% sat within a 2.5cm lateral/posterior and 2.1cm anterior arterial expansion, smaller than Classen fields.
The superior border is the volume lever: no left-sided node sat above L1 or in the renal hilum, supporting a border 1.5cm above the left renal artery rather than T10/T11. Prior inguinal or pelvic surgery is the exception, needing an inferior border 1cm below the femoral head.
In CS IIA/B seminoma with a left-sided primary and no prior inguinal or scrotal surgery, this supports a vascular-referenced CTV without right paracaval or high superior extension; it does not extend to pts with prior pelvic surgery, where inguinal coverage was needed.
The superior border is the volume lever: no left-sided node sat above L1 or in the renal hilum, supporting a border 1.5cm above the left renal artery rather than T10/T11. Prior inguinal or pelvic surgery is the exception, needing an inferior border 1cm below the femoral head.
9 details
Retrospective multicenter imaging review, 4 academic centers, staging scans read by a single abdominal radiologist. Each node transferred to a CT template by its relation to the aorta and renal arteries, with craniocaudal scaling for height.
90 pts, CS IIA/B or recurrent CS I seminoma after orchiectomy, nodes ≤5cm. 40 (44%) relapsed on CS I surveillance at a median 8.5 mo (range 3.2-50.4); 50 (56%) node-positive within 3 mo of diagnosis. 48 (53%) left-sided, 41 (46%) right-sided primaries.
Proposed CTV: 2.5cm lateral/posterior and 2.1cm anterior expansion of arterial vasculature, superior border 1cm above the right or 1.5cm above the left renal artery. Classen acetabular inferior border retained; NCCN 2cm GTV boost and setup margins added on top.
145 nodes, average 1.6 per pt, median size 18 mm. 99% of nodes fell inside the proposed expansion; nodal region was unrelated to CS at presentation (P = 0.16) or primary laterality (P = 0.15).
| Region | % of all nodes | % of pts with ≥1 node |
|---|---|---|
| Para-aortic | 84% | 88% |
| Common iliac | 9% | 12% |
| Pelvic | 7% | 9% |
Classen extended fields (prospective phase II, 2003) are the NCCN- and European consensus-endorsed standard; this map supports Classen's acetabular inferior border but argues the T10/T11 superior border overtreats. MRC TE10 linked smaller fields to less acute GI toxicity and leukopenia. Martin et al. used a 1.4cm aorta/IVC expansion from non-enlarged nodal anatomy.
Single-timepoint CT in many pts, so original nodal position before reaching size criteria was estimated, not observed. Two atypical nodes (1.4%) were excluded from the expansion analysis. Relapses that would emerge outside the reduced field after treatment are unmeasured.
The case for smaller fields rests on second-malignancy risk in a young cohort, with extended fields linked to up to 50% more SMNs than PA strip fields in cited data. The trade the authors accept is a small out-of-field relapse risk, judged salvageable, against lower SMN risk.
Retrospective imaging-defined node map; proposed CTV never tested for relapse or toxicity. Authors themselves limit it to research use pending validation.
- Out-of-field relapse rate when treating the vascular-based CTV prospectively
- Does nanoparticle MRI identify nodes before size criteria change target volumes?
📚 Sources · 📄 1 paper
The longer read
The value of this series is that it replaces bony landmarks, inherited from the pre-CT era, with a target defined by where seminoma nodes actually appear relative to the aorta and renal arteries. The Classen field remains the reference standard for CS IIA/B, and the prospective phase II data behind it already established that dropping the lower pelvis from the field did not raise relapse. This paper extends the same logic upward and laterally: the observed node distribution suggests the T10/T11 superior border and the generous paracaval coverage of conventional fields treat tissue that rarely, if ever, harbors disease. For a left-sided primary, the absence of any PA node right of the aorta and any node above L1 makes the case for trimming the right-sided and cranial volume particularly direct.
The methodological caveat that should move confidence most is what the denominator represents. These are radiographically enlarged nodes, defined by a short-axis cutoff on CT in almost every pt, and many pts had a single scan. The map therefore shows where nodal disease becomes visible, not necessarily where microscopic disease sits at the moment a field is drawn. A reduced CTV built on gross relapse sites could miss subclinical spread that would never appear in this kind of dataset, and that is exactly the failure mode a recurrence map cannot detect. The two atypical right-sided nodes, at the renal hilum and along the gonadal vein, are a reminder that right-sided drainage is less predictable, and the 13% contralateral PA rate for right-sided primaries means asymmetric trimming is a left-sided argument, not a general one.
The second issue is that nothing was treated. There is no relapse rate, no dosimetric comparison and no toxicity endpoint for the proposed volume. The SMN rationale draws on Hodgkin survivor data and modeling, which supports the direction of benefit but not its size for this specific CTV. The authors are candid that the volume belongs in a research setting.
Context has also shifted since publication in 2013. The authors themselves favor surveillance for CS I, and adjuvant RT for CS I has largely receded, so the question this paper most informs is the CS IIA/B field. There, the decision it moves is volume design rather than whether to irradiate: a CT-planned, vascular-referenced CTV with a lower superior border is consistent with these data, while the exception for prior inguinal or scrotal surgery argues for extending inferiorly in that subset. What would make the proposal wrong is a prospective cohort treated to this volume showing marginal or out-of-field relapse clustering near the excluded superior or paracaval regions; until such data exist, the map is best read as a rationale for contouring choices within established field families rather than a replacement for them.